What is involved in a comprehensive kidney transplant donor workup?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Comprehensive Kidney Transplant Donor Workup

A comprehensive kidney transplant donor workup requires a thorough medical, psychosocial, and laboratory evaluation to ensure donor safety and minimize risks to both donor and recipient, including mandatory ABO compatibility testing, HLA typing, cross-matching, and assessment of kidney function through GFR measurement. 1

Initial Screening and Compatibility Testing

Preliminary Mandatory Testing

  • ABO blood type compatibility
  • HLA typing
  • Cross-matching against potential recipient 1
  • Initial screening questions about medical history and motivation for donation 1

Selection Criteria When Multiple Donors Available

  • Degree of HLA matching
  • Donor age
  • Biologically related donors generally preferred over unrelated donors 1

Medical Evaluation Components

Kidney Function Assessment

  • GFR measurement (expressed as mL/min/1.73 m²) rather than serum creatinine alone 1
  • Initial assessment using estimated GFR from serum creatinine (eGFRcr)
  • Confirmation with measured GFR when necessary

Cardiovascular Risk Assessment

  • Indications for cardiac stress testing:
    • Age ≥45 years in men or ≥55 years in women
    • History of smoking
    • Family history of premature coronary artery disease
    • History of dyslipidemia
    • History of hypertension
    • Abnormal ECG (left ventricular hypertrophy, left bundle branch block, ST-T abnormalities) 1

Diabetes/Glucose Metabolism Screening

  • Fasting plasma glucose
  • Oral glucose tolerance test when indicated

Absolute Contraindications

  • Known diabetes mellitus
  • Fasting plasma glucose ≥126 mg/dL on 2+ occasions
  • Plasma glucose ≥200 mg/dL 2 hours after oral glucose challenge on 2+ occasions 1

Relative Contraindications

  • Impaired fasting glucose (110-125 mg/dL)
  • Impaired glucose tolerance (2-hour glucose 140-199 mg/dL) 1

Infectious Disease Screening

  • Serologic screening for viral infections
  • Nucleic acid testing for hepatitis B, hepatitis C, and HIV
  • Additional testing for endemic exposures when indicated 2

Cancer Screening

  • Age-appropriate cancer screening
  • Evaluation of any pre-existing malignancies 3

Pregnancy Considerations

  • Pregnancy testing for women of childbearing potential
  • Counseling about avoiding pregnancy from approval to post-donation recovery
  • Discussion of potential effects on future pregnancies 1

Psychosocial Evaluation

Two-Phase Approach for Unrelated Donors

  1. Phase I: Initial Screening

    • General screening questions about medical history
    • Connection with transplant candidate
    • Reasons for and expectations about donation
    • Knowledge of risks involved 1
  2. Phase II: On-Site Evaluation

    • Detailed psychosocial evaluation (mandatory for unrelated donors)
    • Conducted early in the medical evaluation process
    • Initial interview conducted alone, with additional interview including significant other
    • Evaluation by independent donor team separate from recipient's team
    • "Cooling off" period of at least 2 weeks 1

Key Components of Psychosocial Assessment

  • Verification of voluntary donation without undue pressure
  • Assessment of motivation and expectations
  • Evaluation of psychological stability
  • Assessment of social support system
  • Understanding of risks and benefits
  • Financial considerations 1

Post-Evaluation Decision Making

Framework for Decision-Making

  • Donor candidate, recipient, and transplant program must all agree with decision
  • Transplant program policies must be defensible based on current understanding of risks and benefits
  • Risks should be expressed as absolute rather than relative risks 1

Risk Communication

  • Individualized quantitative estimates of short-term and long-term risks
  • Recognition of associated uncertainty
  • Information presented in an easily understood manner 1

Common Pitfalls to Avoid

  1. Failing to ensure true voluntariness - Always conduct at least part of the psychosocial evaluation in the absence of the recipient, family members, or others who might influence the donation decision 1

  2. Inadequate assessment of long-term risks - Recent evidence shows increased risk of kidney failure in donors, contrary to previous beliefs of negligible risk 1

  3. Overlooking pregnancy-related risks - Women with prior hypertensive disorders of pregnancy require careful evaluation of long-term risks 1

  4. Insufficient "cooling off" period - Ensure donors have adequate time (at least 2 weeks) to consider their decision 1

  5. Neglecting post-donation care planning - A comprehensive plan for donation care and follow-up should be formulated to minimize risks 1

By following this comprehensive approach to donor evaluation, transplant centers can maximize safety for donors while ensuring optimal outcomes for recipients.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.